Michael Thomas Heffernan Insider Trading $KERX KERYX BIOPHARMACEUTICALS INC
Get free email notifications about insider trading for Michael Thomas Heffernan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Thomas Heffernan. Michael Thomas Heffernan is Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Director in Ocata Therapeutics, Inc. ($ACTC) and Director in CORNERSTONE THERAPEUTICS INC ($CRTX) and Chairman, President and CEO in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA) and Director in SYNLOGIC, INC. ($SYBX) and Director in Trevi Therapeutics, Inc. ($TRVI) and in Biohaven Pharmaceutical Holding Co Ltd. ($BHVN).
Michael Thomas Heffernan in KERYX BIOPHARMACEUTICALS INC
Trading Symbol: KERXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Thomas Heffernan: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 13 2018
$KERX Market Capitalization: $574.30M
$KERX Previous Close: $5.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael Thomas Heffernan in KERYX BIOPHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKBA, BHVN, COLL, CRTX, KERX, ACTC, SYBX, TRVI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Heffernan Michael Thomas | Director | Option Exercise | D | 0.00 | 110,000 | 0 | 0 | |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Heffernan Michael Thomas | Director | Sell | D | 0.00 | 20,000 | 0 | 0 | 20 K to 0 (-100.00 %) |
Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Heffernan Michael Thomas | Director | Option Exercise | A | 3.76 | 30,000 | 112,800 | 30,000 | |
Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
Jun 20 2017 | KERX | KERYX BIOPHARMACEU ... | Heffernan Michael Thomas | Director | Option Exercise | A | 6.56 | 30,000 | 196,800 | 30,000 | |
Jun 20 2017 | KERX | KERYX BIOPHARMACEU ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jun 23 2016 | KERX | KERYX BIOPHARMACEU ... | Heffernan Michael Thomas | Director | Option Exercise | A | 6.05 | 50,000 | 302,500 | 50,000 |
Page: 1